skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Sepsis reconsidered: Identifying novel metrics for behavioral landscape characterization with a high-performance computing implementation of an agent-based model

Journal Article · · Journal of Theoretical Biology
 [1];  [1]
  1. Univ. of Chicago Medicine, Chicago, IL (United States). Dept. of Surgery

Objectives: Sepsis affects nearly 1 million people in the United States per year, has a mortality rate of 28–50% and requires more than $20 billion a year in hospital costs. Over a quarter century of research has not yielded a single reliable diagnostic test or a directed therapeutic agent for sepsis. Central to this insufficiency is the fact that sepsis remains a clinical/physiological diagnosis representing a multitude of molecularly heterogeneous pathological trajectories. Advances in computational capabilities offered by High Peformance Computing (HPC) platforms call for an evolution in the investigation of sepsis to attempt to define the boundaries of traditional research (bench, clinical and computational) through the use of computational proxy models. We present a novel investigatory and analytical approach, derived from how HPC resources and simulation are used in the physical sciences, to identify the epistemic boundary con- ditions of the study of clinical sepsis via the use of a proxy agent-based model of systemic inflammation. Design: Current predictive models for sepsis use correlative methods that are limited by patient heterogeneity and data sparseness. We address this issue by using an HPC version of a system-level validated agent-based model of sepsis, the Innate Immune Response ABM (IIRBM), as a proxy system in order to identify boundary conditions for the possible behavioral space for sepsis. We then apply advanced analysis derived from the study of Random Dynamical Systems (RDS) to identify novel means for characterizing system behavior and providing insight into the tractability of traditional investigatory methods. Results: The behavior space of the IIRABM was examined by simulating over 70 million sepsis patients for up to 90 days in a sweep across the following parameters: cardio-respiratory-metabolic resilience; microbial invasiveness; microbial toxigenesis; and degree of nosocomial exposure. In addition to using established methods for describing parameter space, we developed two novel methods for characterizing the behavior of a RDS: Probabilistic Basins of Attraction (PBoA) and Stochastic Trajectory Analysis (STA). Computationally generated behavioral landscapes demonstrated attractor structures around stochastic re- gions of behavior that could be described in a complementary fashion through use of PBoA and STA. The stochasticity of the boundaries of the attractors highlights the challenge for correlative attempts to characterize and classify clinical sepsis. Conclusions: HPC simulations of models like the IIRABM can be used to generate approximations of the behavior space of sepsis to both establish “boundaries of futility” with respect to existing investi- gatory approaches and apply system engineering principles to investigate the general dynamic properties of sepsis to provide a pathway for developing control strategies. Here, the issues that bedevil the study and treatment of sepsis, namely clinical data sparseness and inadequate experimental sampling of system behavior space, are fundamental to nearly all biomedical research, manifesting in the “Crisis of Reproducibility” at all levels. HPC-augmented simulation-based research offers an investigatory strategy more consistent with that seen in the physical sciences (which combine experiment, theory and simulation), and an opportunity to utilize the leading advances in HPC, namely deep machine learning and evolutionary computing, to form the basis of an iterative scientific process to meet the full promise of Precision Medicine (right drug, right patient, right time).

Research Organization:
Lawrence Berkeley National Laboratory, Berkeley, CA (United States). National Energy Research Scientific Computing Center (NERSC)
Sponsoring Organization:
USDOE Office of Science (SC), Advanced Scientific Computing Research (ASCR)
Grant/Contract Number:
AC02-05CH1123
OSTI ID:
1463862
Journal Information:
Journal of Theoretical Biology, Vol. 430, Issue C; ISSN 0022-5193
Publisher:
ElsevierCopyright Statement
Country of Publication:
United States
Language:
English
Citation Metrics:
Cited by: 16 works
Citation information provided by
Web of Science

References (48)

Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock journal March 1998
p55 Tumor Necrosis Factor Receptor Fusion Protein in the Treatment of Patients With Severe Sepsis and Septic Shock: A Randomized Controlled Multicenter Trial journal May 1997
Lenercept (p55 tumor necrosis factor receptor fusion protein) in severe sepsis and early septic shock: A randomized, double-blind, placebo-controlled, multicenter phase III trial with 1,342 patients journal January 2001
Agent-Based Computer Simulation and Sirs: Building a Bridge Between Basic Science and Clinical Trials journal January 2001
In silico experiments of existing and hypothetical cytokine-directed clinical trials using agent-based modeling* journal January 2004
Closing the Scientific Loop: Bridging Correlation and Causality in the Petaflop Age journal July 2010
Small to large, lots to some, many to few: In silico navigation of the Translational Dilemma journal January 2012
Optimization and Control of Agent-Based Models in Biology: A Perspective journal November 2016
A systematic review and meta-analysis of early goal-directed therapy for septic shock: the ARISE, ProCESS and ProMISe Investigators journal May 2015
1,500 scientists lift the lid on reproducibility journal May 2016
A Transcriptomic Biomarker to Quantify Systemic Inflammation in Sepsis — A Prospective Multicenter Phase II Diagnostic Study journal April 2016
Immunosuppression in Patients Who Die of Sepsis and Multiple Organ Failure journal December 2011
Physiologic Stability and Physiologic State journal January 1996
Precision Medicine for Critical Illness and Injury journal January 2016
Motifs, Control, and Stability journal November 2005
Biomarkers of sepsis journal January 2013
T helper cell subset ratios in patients with severe sepsis journal January 1999
Recombinant Human Interleukin 1 Receptor Antagonist in the Treatment of Patients With Sepsis Syndrome: Results From a Randomized, Double-blind, Placebo-Controlled Trial journal June 1994
Treatment of Septic Shock with the Tumor Necrosis Factor Receptor:Fc Fusion Protein journal June 1996
Uncoupling of biological oscillators: A complementary hypothesis concerning the pathogenesis of multiple organ dysfunction syndrome journal January 1996
Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach journal March 2013
Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy journal November 2013
Contradicted and Initially Stronger Effects in Highly Cited Clinical Research journal July 2005
Could a Neuroscientist Understand a Microprocessor? journal January 2017
An Integrated Clinico-Metabolomic Model Improves Prediction of Death in Sepsis journal July 2013
An Algorithm for Systemic Inflammatory Response Syndrome Criteria–Based Prediction of Sepsis in a Polytrauma Cohort* journal January 2016
The Timing of Early Antibiotics and Hospital Mortality in Sepsis journal October 2017
Metabolomics as a Novel Approach for Early Diagnosis of Pediatric Septic Shock and Its Mortality journal May 2013
Validation of a Screening Tool for the Early Identification of Sepsis journal January 2009
Early Detection of Sepsis—A Role for Network Physiology? journal January 2016
Signatures of Subacute Potentially Catastrophic Illness in the ICU: Model Development and Validation* journal January 2016
Metabolite Profiles in Sepsis: Developing Prognostic Tools Based on the Type of Infection* journal January 2016
Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: A phase III, randomized, doubleblind, placebo-controlled, multicenter trial journal January 1997
Circulating Cytokine/Inhibitor Profiles Reshape the Understanding of the SIRS/CARS Continuum in Sepsis and Predict Mortality journal July 2006
Randomized, placebo-controlled trial of the anti-tumor necrosis factor antibody fragment afelimomab in hyperinflammatory response during severe sepsis: The RAMSES Study journal January 2001
Recombinant Humanized Monoclonal Antibody against CD18 (rhu MAb CD18) in Traumatic Hemorrhagic Shock: Results of a Phase II Clinical Trial journal January 2000
Multicenter, double-blind, placebo-controlled study of the use of filgrastim in patients hospitalized with pneumonia and severe sepsis* journal January 2003
Robustness of Cellular Functions journal September 2004
The Impact of Timing of Antibiotics on Outcomes in Severe Sepsis and Septic Shock: A Systematic Review and Meta-Analysis* journal January 2015
Empirical assessment of published effect sizes and power in the recent cognitive neuroscience and psychology literature journal March 2017
Pro- and anti-inflammatory responses are regulated simultaneously from the first moments of septic shock journal June 2011
In Silico Modeling: Methods and Applications to Trauma and Sepsis journal January 2013
Solving Immunology? journal February 2017
Comparison of Sepsis Screening Tools' Ability to Detect Sepsis Accurately journal October 2016
Pharmacoeconomic Implications of New Therapies in Sepsis journal January 2004
Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group journal June 1994
Addressing the Translational Dilemma: Dynamic Knowledge Representation of Inflammation Using Agent-Based Modeling journal January 2012
Biomarkers for Sepsis: What is and What Might Be? journal January 2015

Cited By (10)

The Impact of Stochasticity and Its Control on a Model of the Inflammatory Response journal December 2018
Examining the controllability of sepsis using genetic algorithms on an agent-based model of systemic inflammation journal February 2018
The Crisis of Reproducibility, the Denominator Problem and the Scientific Role of Multi-scale Modeling journal September 2018
Agent‐based models of inflammation in translational systems biology: A decade later journal June 2019
Optimization of Dose Schedules for Chemotherapy of Early Colon Cancer Determined by High-Performance Computer Simulations journal January 2019
Modeling Human Evacuating Behavior in Limited Space Based on Cellular Automata Model journal October 2020
Nested active learning for efficient model contextualization and parameterization: pathway to generating simulated populations using multi-scale computational models journal December 2020
High-throughput cancer hypothesis testing with an integrated PhysiCell-EMEWS workflow journal December 2018
Evaluation of Criteria for the Implementation of High-Performance Computing (HPC) in Danube Region Countries Using Fuzzy PIPRECIA Method journal April 2020
Precision medicine as a control problem: Using simulation and deep reinforcement learning to discover adaptive, personalized multi-cytokine therapy for sepsis preprint January 2018